BrainScope
BrainScope is a pioneering neurotechnology company that leverages AI-powered EEG solutions to revolutionize brain health assessment. Their proprietary platform transforms brain electrical activity into objective, diagnostic insights, initially focusing on mild traumatic brain injury (mTBI). The company has developed the first AI/ML-enabled medical device cleared by the FDA in neurology, which assesses both brain bleeds and concussions at the point of care. This technology offers rapid, radiation-free, and cost-effective biomarkers, demonstrating significant reductions in unnecessary head CT scans and patient length of stay in emergency departments. BrainScope is expanding its offerings to develop novel biomarkers for a range of CNS indications including stroke, neurodegenerative diseases, and behavioral health, aiming to redefine brain health management across acute care, drug development, and consumer health.
BrainScope
BrainScope is a pioneering neurotechnology company that leverages AI-powered EEG solutions to revolutionize brain health assessment. Their proprietary platform transforms brain electrical activity into objective, diagnostic insights, initially focusing on mild traumatic brain injury (mTBI). The company has developed the first AI/ML-enabled medical device cleared by the FDA in neurology, which assesses both brain bleeds and concussions at the point of care. This technology offers rapid, radiation-free, and cost-effective biomarkers, demonstrating significant reductions in unnecessary head CT scans and patient length of stay in emergency departments. BrainScope is expanding its offerings to develop novel biomarkers for a range of CNS indications including stroke, neurodegenerative diseases, and behavioral health, aiming to redefine brain health management across acute care, drug development, and consumer health.